Zoltan Ungvari to Serotonin Uptake Inhibitors
This is a "connection" page, showing publications Zoltan Ungvari has written about Serotonin Uptake Inhibitors.
Connection Strength
0.881
-
Use of selective serotonin reuptake inhibitors and myocardial infarction. Circulation. 2002 Apr 09; 105(14):e84.
Score: 0.195
-
Selective serotonin-reuptake inhibitor antidepressants increase the risk of falls and hip fractures in elderly people by inhibiting cardiovascular ion channels. Med Hypotheses. 2001 Oct; 57(4):469-71.
Score: 0.188
-
Serotonin reuptake inhibitor fluoxetine decreases arteriolar myogenic tone by reducing smooth muscle [Ca2+]i. J Cardiovasc Pharmacol. 2000 Jun; 35(6):849-54.
Score: 0.171
-
Fluoxetine dilates isolated small cerebral arteries of rats and attenuates constrictions to serotonin, norepinephrine, and a voltage-dependent Ca(2+) channel opener. Stroke. 1999 Sep; 30(9):1949-54.
Score: 0.163
-
Serotonin reuptake inhibitors fluoxetine and citalopram relax intestinal smooth muscle. Can J Physiol Pharmacol. 2001 Jul; 79(7):580-4.
Score: 0.046
-
Speculations on difference between tricyclic and selective serotonin reuptake inhibitor antidepressants on their cardiac effects. Is there any? Curr Med Chem. 1999 Jun; 6(6):469-80.
Score: 0.040
-
Serotonin reuptake inhibitor, fluoxetine, dilates isolated skeletal muscle arterioles. Possible role of altered Ca2+ sensitivity. Br J Pharmacol. 1999 Jun; 127(3):740-6.
Score: 0.040
-
Review of cardiovascular effects of fluoxetine, a selective serotonin reuptake inhibitor, compared to tricyclic antidepressants. Curr Med Chem. 1998 Oct; 5(5):381-90.
Score: 0.038